2m 2m 2m 2m 2m 2m 2m
ORGANGNSS HLDG-A (ORGO)
NASDAQ
$2.41-$0.03 (-1.03%)
Price as of Jun 23, 2026 4:37 PM EDT- $312.7MMarket Cap
- -27.25%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ORGANGNSS HLDG-A (ORGO)
$2.41-$0.03 (-1.03%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 563.0M +16.80% | 482.0M +11.29% | 433.1M -3.94% | 450.9M -3.67% | |
Cost of Revenue | 137.5M +18.82% | 115.7M +8.70% | 106.5M +1.39% | 105.0M -8.04% | |
Gross Profit | 425.5M +16.16% | 366.3M +12.14% | 326.7M -5.56% | 345.9M -2.26% | |
Sales and Marketing Expense | 326.2M +10.77% | 294.5M +9.18% | 269.8M -4.95% | 283.8M +13.43% | |
Research and Development Expense | -44.5M -11.40% | -50.3M +13.27% | -44.4M +11.61% | -39.8M +29.34% | |
Depreciation and Amortization Expense | 3.3M -2.35% | 3.4M -30.81% | 4.9M +0.72% | 4.9M -1.33% | |
Total Operating Expenses | 519.5M +41.32% | 367.6M +17.02% | 314.1M -2.92% | 323.6M +15.17% | |
Operating Profit | 44.7M +3,583.55% | -1.3M -110.24% | 12.5M -43.84% | 22.3M -69.41% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -2.2M +9.01% | -2.0M -72.24% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -2.2M +9.01% | -2.0M -72.24% | |
Total Nonoperating Income and Expense | 2.3M +249.34% | -1.5M -28.55% | -2.1M +5.49% | -2.0M -77.86% | |
Income before Taxes | 47.0M +1,773.32% | -2.8M -127.01% | 10.4M -48.76% | 20.3M -68.20% | |
Income Taxes | 9.9M +370.94% | -3.7M -167.34% | 5.4M +14.67% | 4.8M +115.27% | |
Extraordinary Items | N/A N/A | 0 N/A | 0 N/A | N/A N/A | |
Net Income | 37.0M +4,201.05% | 861,000 -82.59% | 4.9M -68.16% | 15.5M -83.63% | |
Net Income from Continuing Operations Applicable to Common | 20.0M +2,236.82% | -937,000 -109.02% | 10.4M -48.76% | 20.3M -78.63% | |
Basic EPS and Net Income | 0.16 +1,700.00% | -0.01 -125.00% | 0.04 -66.67% | 0.12 -83.78% | |
Diluted EPS and Net Income | 0.15 +1,600.00% | -0.01 -125.00% | 0.04 -66.67% | 0.12 -83.10% | |
Basic Weighted Average Shares | 126.7M -3.75% | 131.7M +0.34% | 131.2M +0.89% | 130.1M +1.36% | |
Diluted Weighted Average Shares | 130.2M -1.08% | 131.7M -0.81% | 132.7M +0.27% | 132.4M -0.96% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 93.7M -30.90% | 135.6M +30.56% | 103.8M +1.33% | 102.5M -10.05% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 93.7M -30.90% | 135.6M +30.56% | 103.8M +1.33% | 102.5M -10.05% | |
Total Current Assets | 362.2M +26.67% | 285.9M +27.06% | 225.0M +1.09% | 222.6M -1.93% | |
Accumulated Depreciation | 88.1M +20.78% | 72.9M -0.32% | 73.2M +16.54% | 62.8M +8.78% | |
Property and Plant and Equipment and Net | 103.7M +16.36% | 89.1M -23.32% | 116.2M +13.43% | 102.5M +29.44% | |
Total Long-Term Assets | 9.2M +83.88% | 5.0M -16.44% | 6.0M +294.08% | 1.5M -1.11% | |
Total Assets | 598.7M +20.25% | 497.9M +8.23% | 460.0M +2.37% | 449.4M +1.38% | |
Income Taxes Payable | 0 -100.00% | 4.3M +53.13% | 2.8M +6.63% | 2.6M N/A | |
Total Short-Term Debt | 0 -100.00% | 5.5M 0.00% | 5.5M +20.89% | 4.5M +70.86% | |
Total Current Liabilities | 100.1M +29.23% | 77.5M -3.77% | 80.5M +7.31% | 75.0M -8.51% | |
Total Long-Term Debt | 0 -100.00% | 60.7M 0.00% | 60.7M -8.28% | 66.2M -6.41% | |
Total Long-Term Liabilities | 1.2M +33.45% | 894,000 -26.30% | 1.2M +8.11% | 1.1M -27.94% | |
Total Liabilities | 164.8M +46.41% | 112.6M -37.93% | 181.4M -1.27% | 183.7M -8.71% | |
Retained Earnings | -3.1M -92.33% | -40.1M -2.10% | -41.0M -9.56% | -45.3M -24.67% | |
Total Stockholders Equity | 300.1M +14.16% | 262.9M -5.66% | 278.7M +4.89% | 265.7M +9.76% | |
Total Shares Outstanding | 127.0M +0.97% | 125.7M -4.25% | 131.3M +0.30% | 130.9M +1.74% | |
Cash Flow | |||||
Cash from Operating Activities | -10.3M -172.56% | 14.2M -54.04% | 30.9M +24.37% | 24.9M -59.89% | |
Capital Expenditures | 14.2M +41.06% | 10.0M -58.82% | 24.4M -28.13% | 33.9M +8.58% | |
Cash from Investing Activities | -14.2M +41.06% | -10.0M -58.82% | -24.4M -28.13% | -33.9M +8.58% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -17.4M -162.81% | 27.6M +602.03% | -5.5M +150.34% | -2.2M +112.26% | |
Financials Ratio | |||||
Gross Margin | 75.57% -0.55% | 75.99% +0.76% | 75.42% -1.68% | 76.71% +1.46% | |
Operating Margin | 7.94% +3,082.01% | -0.27% -109.21% | 2.89% -41.54% | 4.95% -68.25% | |
Return on Assets | 6.75% +3,656.34% | 0.18% -83.47% | 1.09% -68.75% | 3.48% -86.47% | |
Return on Equity | 13.15% +4,036.67% | 0.32% -82.50% | 1.82% -70.30% | 6.12% -87.49% | |
Revenue Growth | 16.80% +48.81% | 11.29% +386.75% | -3.94% +7.36% | -3.67% -109.56% | |
Current Ratio | 3.62 -1.99% | 3.69 +32.03% | 2.80 -5.79% | 2.97 +7.20% | |
Cash Ratio | 0.94 -46.53% | 1.75 +35.66% | 1.29 -5.58% | 1.37 -1.68% | |
Debt-to-Equity Ratio | 0.00 -100.00% | 0.25 +5.97% | 0.24 -10.77% | 0.27 -12.20% | |
Debt-to-Assets Ratio | 0.00 -100.00% | 0.13 -7.64% | 0.14 -8.57% | 0.16 -4.89% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow